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IN 1960, Kahlson suggested that the histamine-forming capacity of rat tissues
is related to the processes ofgrowth, regeneration and repair. He found that the
foetal liverproduces histamine at a fast rateduring the last fewdays ofpregnancy,
and when this capacity is reduced growth of the foetus ceases. The high activity
in rat foetal liver has recently been confirmed by Telford and West (1961a), but
these authors found in addition that the enzyme forming histamine (histidine
decarboxylase) is lacking in the rat foetus before the 13th day of pregnancy and
in the young rat during its first 10 days of life-two periods when active growth
is taking place.
The starting point of the present study was the finding by Mackay, Marshall
and Riley (1960) that a transplantable rat hepatoma possesses a high histidine
decarboxylase activity. Analyses ofthis tumour at different stages of its develop-
ment showed that there is an association between the ability to form histamine
and growth, and a preliminary note has been published (Kameswaran and West,
1961). It was also found however that other rapidly-growing experimental
tumours of rat and human origin possess little or no histidine decarboxylase
activity, and the problem needed further investigation.
MATERIALS AND METHODS
Female rats (100-130 g. in weight) of the August strain implanted with the
hepatoma (F-hep) were secured from the Chester Beatty Research Institute,
London, through the kindness of Professor A. Haddow. The hepatoma had been
induced in this strain of rat five years earlier by feeding first 0-3 per cent (w/w) 4'-fluoro-4-dimethylaminoazobenzene in a 20 per cent protein diet for 3 months
and then 0-6 per cent (w/w) of the dye for a further 3 months ; it had been main-
tained by serial subcutaneous implantation into August rats. At various times
afterimplantation, a group of 3 rats was killed, the tumour from each animalbeing carefully dissected out' weighed and ground in a mortar with sand and Ty-rode solution ready for the estimation of its histidine decarboxylase activity. The
tumour, after about 14 days of growth, was subsequently implanted into albino
rats (40-100 g. in weight) of the Wistar strain, obtained from the Agricultural Research Council's Field Station at Comptom. The inoculum for implantation
was prepared by mincing the excised tumour with scalpels and suspending it in
Ringer Locke solution devoid of glucose. About 300 mg. of tissue suspended in
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0-5 ml. solution was injected subcutaneously into the shaved right flank of the
Wistar rats. All instruments and glassware were sterilised and reasonableaseptic
conditions were maintained throughout. The food was a cube diet (No. 41B,
Associated London Flour Millers, Ltd.) and the rats were allowed drinking water
containing 0-01 per cent (w/v) chloramphenicol ad libitum. They were housed at
70 4- iO F. (:)"V C.). Immediately after implantation, each rat was injected sub-
cutaneously near the nape of the neck with 60 mg./kg. cortisone acetate, the in-
jection being repeated on alternate days for a total of 4 injections. Groups of 3
Wistar rats were killed at various times after implantation and the histidine de-
carboxylase activity of each tumour determined. The tumour in other Wistar
rats after about 14 days of growth (the optimal time for transplantation) was
subsequently implanted into other generations of albino Wistar rats, as described
above.
Other tumours used in thisstudy were the Walkertumour, a humanepidermoid
carcinoma of buccal origin (HEp 3) and a human sarcoma originating in the soft
part ofthe leg (HS 1), each growing subcutaneously in Wistar rats (Toolan, 1954),
and 2, hepatoma which occurred spontaneously in a hamster and which had been
maintained at the Chester Beatty Research Institute, London, by serial subcu-
taneous implantation into hamsters.
Measurement of hi-stamine formation in vitro.-The method of Waton (1956),
slightly modified and described in detail by Telford and West (1961b), was used.
Briefly, tissue from freshly killed animals was weighed and ground in a glass
mortar with a little sand and Tyrode solution (5 ml./g. tissue). The supernatant
fluid was then incubated for 3 hours with L-histidine (I5 mg.) in the presence of
a phosphate buffer, aminoguanidine (to inhibit histaminase, the enzyme inacti-
vatinghistamine) and benzene (acatalyst). Thehistamineformed wasthenassayed
on the isolated atropinized ileum of the guinea-pig, the specificity of the response
being checked by mepyramine maleate. In each experiment, mixtures with and
wi'thout the substrate (histidine) and mixtures containing boiled homogenate or
no homogenate were incubated and assaved for histamine. The mean bistamine
content of the mixtures incubated in the presence of histidine less the mean hist-
amine content of mixtures incubated in the absence of histidine gave the amount
of histamine formed from histidine. The amounts of histamine formed per gram
of tissue and per tissue were used as indices of histidine decarboxylase activitv.
Each result is the mean of at least two experiments.
The histamine content of the mixtures containing boiled homogenate was the
tissue histamine freely extractable by Ty-rode solution. In nearly every sample
of tumour extract, this estimate was similar to that found after extraction of the
tumour with 10 per cent (w/v) trichloroacetic acid (5 ml./g.).
Inhibition of histamine formation -Semicarbazide and a-methyl-dihydroxy-
phenylalanine (a-methyl-DOPA) were each used in daily intraperitoneal doses
of 75 mg./kg. to inhibit the activity of histidine decarboxylase in the hepatoma
implanted into the sixthgeneration ofWistar rats. Concentrations ofeacb inhibitor
were also used in incubation experiments to test their in vitro activity.
Formation of 5-hydroxytr.yptamine (5-HT).-The power of the hepatoma from
August rats to decarboxylate 5-hydroxytryptophan was tested by the method of
Price and West (1960). Briefly, the tumour homogenate was incubated with the
substrate and the 5-HT formed was assayed on the isolated atropinized rat uterus.
Specificity of the response was checked by 2-bromo-lysergic acid diethylamide.133 HISTAMINE AND TUMOUR GROWTH
The 5-HT-forming capacity of the foetal and adult liver ofAugust rats was also
determined.
RESULTS
Histamineformation in the rat heptoma
Rats ofthe August strain.-No histidine decarboxylase activity was detected in
the tumour tissue until about 7 days after implantation, when the optimal pH
value for activity was 6-5 and benzene did not increase the Yield of histamine.
Theseoptimal conditions for incubation did notchange asgrowth ofthehepatoma
-w
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FIG. I.-Effect ofpH on the rate ofhistamine formation in 3 hours in thehepatoma and in the foetal (O 0) and adult (O 0) liver ofAugust rats. Foetuses used at
the 16th day of gestation. Hepatoma used at the 21st day of growth. Note the different
scales of histaniine formation. The opti-rnal pH for the footal liver and hepatoma is 6-5, whereas it is 8-0 for the adult liver.
proceeded; they are similar to those for rat foetal liver and unlike those found
for adult liver (Telford and West, 1961b). The result using tumour tissue 21 days after implantation is shown in Table I and Fig. 1, and compared wi-th those of
foetal and adult liver taken from August rats. Enzyme activity per gram of
hepatoma is of a similar order as that of foetal liver but theweight of the tumour
is manytimes that of the foetal liver and so the histamine-forming capacity ofthe
hepatoma is nearly fifty times greater.
The results shown in Table II indicate that the histamine-forming capacity of
the hepatoma reached a high level 11-14 days after implantation. Tendays later,
enzyme activity again increased although by this time there was much necrosis
of the tumour. Nevertheless, the capacity of the hepatoma to form histamine
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TABLEL-Hidamine and 5-HT Formation in the Hepatoma and in the Foetal and
Adult Liver ofAugu8t Rat8. Incubationfor 3 hour8 at Optimal pH
Histan-iine fori-nation
r --A- 'N
Incubation
requirements
'N pg./
pH Benzene ug.Ig. tissue
6-5 Absent 419 1675
6.5 Absent 475 38
8-0 Present 10 70
5-HT fori-nation
yg./
pg./g. tissue
0- 8 3- 2
1-2 0.1
130 910
Tissue used
Hepatoma (21st day of growth)
Foetal liver (16th day- ofgestation).
Adult liver . .
.
Formation in the
hours at pH 6-5.
TABLE II.-Effect of Age of Tumour on the Rate of Hi-stamine
Hepatoma of Groups of 3 Augu8t Rats. Incubation for 3
Hi8tamine Estimated After Extraction with Tyrode Sclution
Histamine formed
pg-/g- yg./tumour
.
10.5 1
1186- 3 474
945- 0 1,228
652 5 1,305
418- 8 1,675
420- 4 3,573
1000.0 33,000
Mean weight
of tumour
(g.)
0.1
0- 4
1- 3
2- 0
4- 0
8- 5
33 0
Histainine content
f' I
pg.Ig. pg./tumour
22- 5 2
63- 8 25
55- 0 71
35- 0 70
18- 8 75
17
- 5 148
50- 0 1,650
Day after
implantation
7
11
14
17
21
28
38
for a normal tissue, the tumourbeing capable offorming some 33 mg. ofhistamine
in 3 hours. A few days later, the tumours burst and the animals died.
In a few experiments, some of the August rats were treated with 4 doses of
cortisone (60 mg./kg.) in an attempt to enhance growth ofthe hepatoma, but this
did not occur and the tumour did not appear to be morehealthy than thatgrowing
in the absence of cortisone. Moreover, the histidine decarboxylase activity of the
tumour of the cortisone-treated animals 20 days after implantation was only
20 per cent more than that of untreated animals. In other experiments, growth
of the hepatoma was followed in August rats either depleted oftheir histamine by
chronic treatment with 5 mg./kg. polymyxin B or depleted of their 5-HT by
chronic treatment with 0-5 mg./kg. reserpine (Parratt and West, 1957). Whereas
removal of histamine did not affect the size of the tumour or the enzyme activity
when this was tested 15 days after implantation, the tumours in the rats depleted
of 5-HT grew to at least 4 times the size ofthose in untreated rats andactivity was
correspondingly increased. When the treatment with polymyxin B was extended
to 35 days to reduce the tissue levels of both histamine and 5-HT (Telford and
West. 1960), the tumours were also about 4 times the size of those in untreated
rats. These results may be linked with the findings that the presence of histamine
and 5-HT in the tissues of rats confers immunity to infection by Staphylococcus
aureu,s (Mishra and Sanyal, 1959), that 5-HT increases the phagocytic power of
monkey leucocytes in vitro (Northover, 1958), that injections of histamine cause
increased phagoeytosis of BCG in rats (Kato and G6zsy, 1956), and that mast cell
depletion (by compound 48/80) after tumour implantation increases the survival
and growth of a rat sarcoma (Scott, Scheline and Stone, 1958).
Rat,g of the Wi8tar 3train.-The hepatoma in the August strain continued to
grow when it was implanted into cortisone-treated rats of the Wistar strain.135 HISTAMINE AND TUMOUR GROWTH
Growth was always poor in the Wistar rats when cortisone was omitted, and
previous X-irradiation did not act synergistically with the cortisone. Depletion
of tissue histamine or 5-HT also did not result in a significant increase in growth.
The results shown in Table III were obtained using cortisone-treated Wistar rats.
It will be noted that the transplant increased inweight muchquicker than in the
August rats, the peak occurring after about II days. Although the histidine de-
carboxylase activity when calculated per gram of tumour never reached the bigh
values found in August rats, the capacity of the tumour to form histamine was
ashigh in the initialphases. About 14days afterimplantation, activity decreased
rapidly although the size of the tumour remained relatively large, probably, as a
result ofnecrosis. Whereas theAugust rats died about 40days afterimplantation,
the tumour in the Wistar ratsby this time hadregressed so much that the animals
had fufly recovered from the effects ofimplantation. The optimal conditions for
incubation of extracts of tumours of Wistar rats were similar to those ofAugust
rats. A compacison ofhistamine-forming capacity and the growth ofthe tumours
in both strains of rat is shown in Fig. 2 and 3.
TABLE III.-Effect of Age of Tumour on the Rate of Histamine Formation in the
Hepatoma Implanted Into Groups of 3 Wistar rats. Incubationfor 3 hours at
pH 6-5. Histamine Content Estimated After Extraction with Tyrode Solution.
Mean weight Histamine forined Histamine content
Day after of tumour A ___1 e-
A
implantation (g.) ug./g. ug./tumour Yg-1g- jug./tumour
7 2- 8 46 128 4-2 12
11 4-4 275 1210 11-6 51
14 3-3 352 1162 21-8 72
21 3-1 18 57 0-6 2
38 1-2 5 6 0 0
The hepatoma implanted in Wistar rats was then transplanted through 21
generations. At about the 14thday ofgrowth in each generation (when the trans-
plant was made into the next generation), the tumours were also tested for their
ability to form histamine from histidine. The results are shown in Table IV. For
10 generations the enzyme activity was maintained at a high rate, but subse-
TABLE IV.-The Rate ofHistamine Formation by Hepatoma taken at about the 14th
day of Growth in Different Generations of Wistar Rats. Incubationfor 3 hour8
atpH 6-5. Estimates ofHistamine Content Made After Extraction with Tyrode
Solution.
Mean weight Histamine formed Histamine content
Generation of three t A
r A, _'%
number tumours (g.) ug-1g. ug./tumour Fg.1g. pg./tumour
I 2-0 581 1162 50-0 100
2 1-6 488 778 12-5 20
3 3-9 206 804 43-8 171
4 4-1 455 1825 33-5 139
5 4-1 268 1072 43-8 176
6 5-8 219 1168 31-3 180
7 3-3 352 1162 21-8 72
9 4-4 275 1210 36-2 159
10 3-8 375 1415 37-5 104
15 3-5 50 175 25-0 88
21 1.9 50 95 15.0 29136 G. A. H. BUTTLE, JEAN EPERON, LALITHA KAMESWARAN AND G. B. WEST
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Fi(,,,. 2.-Effect of age of tumour on the rate of hitai-iiiiie formation in hepatonia implanted in
August (*..O) and Wistar (0..O) rats. Incubation for 3 hours at pH 6-5. Note
that after about 14 days the tumour in Wistar rats produces less histamine whereas that
in August rats it-icreases its pi-oductioii.
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FIG. 3.-Effect of age of tumour oii the growth of hepatoma grafted in August (*..O) and Wistar (0--O) rats. Note that after about 14 days the tumour ceases to grow in
Wistar rats whereas that in August rats continues to grow.137 HISTAMINE AND TUMOUR GROWTH
quently it was markedly reduced and growth became inconsistent. It may be
that the inoculum in the later generations was not homologous and growth was
not ofhepatic cells only.
Effect of inhibitors of histidine decarboxylase
The results shown in Table V indicate that both semicarbazide anda-methyl-
DOPA reduced the growth and the histidine decarboxylase activity of the hepa-
toma, this effect being particularly marked with semicarbazide. The activity of
enzymes other than histidine decarboxylase may also have been altered as the
doses of inhibitors were relatively high. The addition of these inhibitors to the
incubation mixtures containing the tumour extract from untreated rats only
reduced the enzyme activity by 50 per cent when concentrations as high as
10-4 Mwere used.
TABLEV.-Effect of Semicarbazide and a-methyl-DOPA on the Rate of Histamine
Formation by Hepatoma taken at the 14th day of Growthof the 6th Generatioitof
Wistar Rats. Incubationfor 3 hours atpH 6-5. Estimate8ofHistamine Content
Made After Extraction with Tyrode Solution.
Mean weight Histamine formed Histamine content
of three A ---"% r
Treatment tumours (g.) lAg.1g. pg./tumour jAg-1g. pg./tumour
None 5- 8 219 1168 31-3 180
a-methyl-DPOA 5.0 81 405 18-8 94
Semicarbazide 2- 5 103 258 21- 8 55
Histamineformation in other tumours
Four tumours other than the rat hepatoma were tested for their histamine-
forming capacity, and the results (Table VI) show that none possesses much
activity. The three rat tumours had traces of histidine decarboxylase activity
II days after implantation, but the hamster hepatoma was completely devoid of
enzyme activity at all times. Fig. 4 compares the rate of histamine formation of
the Walker tumour with its growth over 21 days (i.e. until about the time when
the rat dies). The results in Table VI show that, with the exception of the rat
hepatoma F-hep, the histamine-forming capacity of the tumours tested is not
related to growth of these tumours.
TABLEVI.-Effect of Age of Tumour on the Rate of Histamine Formation
(Itg./Tumour). Incubationfor 3 hours at OptimalpH
Day after implantation
Optimal A
--I
Tumour Species pH 7 11 14 21 38
Hepatoma F-hep Rat (August) 6.5 1 474 1228 1675 33,000 Hepatoma F-hep Rat (Wistar) 6- 5 128 1210 1162 57 6
HS I Rat (Wistar) 7-5 1 3 0 0 0
HEp 3 Rat (Wistar) 8-0 2 6 1 0 0
Walker Rat (Wistar) 8- 0 1 3 9 2
Hepatoma Hamster 0 0 0 0 0
Histamine content of rat hepatoma
The histamine coiitent of the hepatoma implanted into August and Wistar
rats is shown in Tables II and 111. The tumour contained about 70 /tg. histamine138 G. A. H. BUTTLE, JEAN EPERON, LALITHA KAMESWARAN AND G. B. VvEST
when tested between the second and third week after grafting in August rats,
and thereafter the value increased abruptly until more than I mg. of histamine
was finally located free in the tumour. These values generally were a reflection
of the corresponding histamine-forming capacities of the tumour. In Wistax rats
a similar value of about 70 Itg. histamine was reached 14 days after grafting but
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Fic,,. 4.-Effect of age oii the growth (*..O) and rate of Iiistamine formatioii (0..O)
of the Walker tumour in Wistar rats. Incubation for 3 hours at pH 8-0.
thereafter the content, as with the histidine decarboxylase activitv, decreased
sharply. Similar relationships between the histamiiie content and histidine de-
carboxylase activity of the hepatoma grafted into Wistar rats were noted when
the values at about the 14th day ofgrowth in manygenerations were found (Table
IV) and when the effects ofinhibitors of histidine decarboxylase were investigated
(Table V).
Formation of 5-hydroxytryptamine by rat hepatoma
As shown in Table 1, the hepatoma after 21 days in August rats was capable
of decarboxvlating only a few micrograms of 5-hydroxytryptophan, and in this
respect it resembled the foetal liver and not the adult liver. The hepatoma was
also tested at other stages ofgrowth but activity was always less than that found zn
at 21 days.
DISCUSSION
The results show in the first place that there is a relationship between growth
and histamine-forming capacity of the rat hepatoma F-hep. As growth continues
as in August rats, the activity of the enzyme forming histamine increases ; when139 HISTAMINE ANI) TUMOUR GROWTH
growtft ceases as in Wistar rats after about 14 days, the activity declines; when
growth is slowed, as in Wistar rats given inhibitors of histidine decarboxylase,
activity is reduced. The enzymeactivity has been estimatedby an in vitro method
but the results obtained probably apply to in vivo conditions since during the
present study it has been found, for example, that the urinary output of free
histamine by August rats 20-30 days after implantation of the hepatoma is more
than 20 times that ofAugust rats not bearing the tumour.
The histological picture of the rat hepatoma used was ty-pical of actively
growing tumour tissue and consisted of round and polygonal cells closely packed
togetherforming sheets ; in someregions, there were indications ofdifferentiation
into hepatic lobules. lt seems therefore to be a tumour arising from the foetal
type ofcell, since the conditions for estimating its optimal histidine decarboxylase
activity (e.g. pH 6-5 and absence of benzene) are similar to those for rat foetal
liver and unlike those for rat adult liver. Further, both the tumour and the foetal
liver have feeble 5-hydroxytryptamine-forming capacities whereas the adult liver
is rich in this respect. The hepatoma was induced inAugust rats and in this strain
of rat it continues to grow until death. When implanted in rats of the Wistar
strain however,growth ceasesafter some20daysandregression occurs,probablydue
to the antigenicity of the heterologous strain. The tumour grew better in Wistar
rats treated with cortisone than in untreated Wistar rats, but this was not so for
August rats. However, growth was improved in August rats by depleting the
tissues of their histamine or 5-HT (whereas depletion in Wistar rats did not
always improve growth).
It is not clear how the histamine-forming capacityis linked with growth of the
hepatoma. The function of the histidine decarboxylase may be to produce hist-
amine and so dilate blood vessels to increase the bloodsupply to the tumour tissue.
As the tumour enlarges, more is needed and so more histamine may be formed to
dilate further blood vessels. On the other hand, the enzyme may be present only
to remove histidine in excess of the needs of the tumour. The histamine formed
by the action of the enzyme freely diffuses away and is excreted by the host-
although some is found in the tumour itself, it is not bound to the tumour tissue
as extraction with Tyrode solution yields as much as extraction with trichloro-
acetic acid. Thus it appears that the tumour does not require the histamine for
an internal function.
In the tumours other than the rat hepatoma, there is no relationship between
histamine-forming capacity and growth ; growth continues without the need to
produce histamine. This isparticularlyapparent withthe hamsterhepatomawhere
no enzyme activity is found at any time. It is also ofinterest that the foetal liver
of the hamster possesses little histidine decarboxylase activity (Kameswaran and
West, 1962). The other three tumours in the rat continued to grow when the
enzyme activity was nearly zero, and further work is iieeded with otber types of
tumour.
SUMMARY
1. There is a relationship between the histidine decarboxylase activitv and
growth of atransplantable rathepatoma(F-hep). Onthe otherhand, otherrapidly-
growing tumours of rat and human origin lack this enzyme.
2. The characteristics of the rat hepatoma resemble those of foetal rat liver
and are unlike those ofadult rat liver. Forexample, the enzymeforming histamine140 G. A. H. BUTTLE, JEAN EPERON, LALITHA KAMESWARAN AND G. B. WEST
in the hepatoma, like that in the foetal liver, requires a pH value of 6-5 but no
benzene.
3. The rathepatoma induced in August rats has beentransplantedthrough ten
generations ofcortisone-treated Wistar rats without loss ofhistidinedecarboxylase
activity. Regression of the tumour bas always occurred in Wistar rats twenty
days after grafting.
4. Potent inhibitors of histidine decarboxylase slightly reduce the growth and
enzyme activity of the rat hepatoma.
It is a pleasure to acknowledge a grant from the British Empire Cancer
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